aspirin 845 MG / caffeine 65 MG [Stanback Headache Powder Reformulated Jan 2011]
- RxCUI
- 1053325
- RxNorm name
- aspirin 845 MG / caffeine 65 MG [Stanback Headache Powder Reformulated Jan 2011]
- Term type
- SBDC
- Status
- Active
- Updated
- 2026-07-15 00:12:14
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 022011
- Active start
- 022011
- Multiple ingredient
- YES
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| 845 MG / 1 EACH | aspirin | ||
| 65 MG / 1 EACH | caffeine |
Derived Ingredient Concepts#
Source Vocabulary Codes#
| Code type | Value | Category |
|---|---|---|
| PRESCRIBABLE | Y | ATTRIBUTES |
| RXNAV_STR | aspirin 845 MG / caffeine 65 MG [Stanback Headache Powder Reformulated Jan 2011] | NAMES |
| RxNorm Name | aspirin 845 MG / caffeine 65 MG [Stanback Headache Powder Reformulated Jan 2011] | NAMES |
| TTY | SBDC | ATTRIBUTES |
| RxCUI | 1053325 | CODES |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | A01AD | Other agents for local oral treatment | ATC1-4 | aspirin | |
| ATC | D11AX | Other dermatologicals | ATC1-4 | caffeine | |
| ATC | B01AC | Platelet aggregation inhibitors excl. heparin | ATC1-4 | aspirin | |
| ATC | N02BA | Salicylic acid and derivatives | ATC1-4 | aspirin | |
| ATC | N06BC | Xanthine derivatives | ATC1-4 | caffeine | |
| FDASPL | D014970 | Xanthines | CHEM | has_chemical_structure | caffeine |
| FDASPL | N0000175739 | Central Nervous System Stimulant | EPC | has_epc | caffeine |
| FDASPL | N0000175790 | Methylxanthine | EPC | has_epc | caffeine |
| FDASPL | N0000175722 | Nonsteroidal Anti-inflammatory Drug | EPC | has_epc | aspirin |
| FDASPL | N0000175578 | Platelet Aggregation Inhibitor | EPC | has_epc | aspirin |
| FDASPL | N0000175729 | Central Nervous System Stimulation | PE | has_pe | caffeine |
| MEDRT | D001241 | Aspirin | CHEM | has_ingredient | aspirin |
| MEDRT | D002110 | Caffeine | CHEM | has_ingredient | caffeine |
| MEDRT | D001049 | Apnea | DISEASE | may_treat | caffeine |
| MEDRT | D001172 | Arthritis, Rheumatoid | DISEASE | may_treat | aspirin |
| MEDRT | D001778 | Blood Coagulation Disorders | DISEASE | ci_with | aspirin |
| MEDRT | D001791 | Blood Platelet Disorders | DISEASE | ci_with | aspirin |
| MEDRT | D002544 | Cerebral Infarction | DISEASE | may_prevent | aspirin |
| MEDRT | D002644 | Chickenpox | DISEASE | ci_with | aspirin |
| MEDRT | D002675 | Child, Preschool | DISEASE | ci_with | aspirin |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | aspirin |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | caffeine |
| MEDRT | D005221 | Fatigue | DISEASE | may_treat | caffeine |
| MEDRT | D005334 | Fever | DISEASE | may_treat | aspirin |
| MEDRT | D006073 | Gout | DISEASE | may_treat | aspirin |
| MEDRT | D006396 | Hematemesis | DISEASE | ci_with | aspirin |
| MEDRT | D006474 | Hemorrhagic Disorders | DISEASE | ci_with | aspirin |
| MEDRT | D007223 | Infant | DISEASE | ci_with | aspirin |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | aspirin |
| MEDRT | D002546 | Ischemic Attack, Transient | DISEASE | may_prevent | aspirin |
| MEDRT | D008551 | Melena | DISEASE | ci_with | aspirin |
| MEDRT | D009203 | Myocardial Infarction | DISEASE | may_prevent | aspirin |
| MEDRT | D009298 | Nasal Polyps | DISEASE | ci_with | aspirin |
| MEDRT | D010003 | Osteoarthritis | DISEASE | may_treat | aspirin |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | aspirin |
| MEDRT | D010146 | Pain | DISEASE | may_treat | aspirin |
| MEDRT | D011225 | Pre-Eclampsia | DISEASE | may_prevent | aspirin |
| MEDRT | D011263 | Pregnancy Trimester, Third | DISEASE | ci_with | aspirin |
| MEDRT | D012213 | Rheumatic Fever | DISEASE | may_treat | aspirin |
| MEDRT | N0000000160 | Cyclooxygenase Inhibitors | MOA | has_moa | aspirin |
| MEDRT | N0000000133 | Enzyme Inhibitors | MOA | has_moa | caffeine |
| MEDRT | N0000008322 | Bronchodilation | PE | has_pe | caffeine |
| MEDRT | N0000008331 | Cardiovascular Activity Alteration | PE | has_pe | caffeine |
| MEDRT | N0000008567 | Decreased Collecting Duct Water Permeability | PE | has_pe | caffeine |
| MEDRT | N0000008831 | Decreased Platelet Activating Factor Production | PE | has_pe | aspirin |
| MEDRT | N0000008832 | Decreased Platelet Aggregation | PE | has_pe | aspirin |
| MEDRT | N0000008836 | Decreased Prostaglandin Production | PE | has_pe | aspirin |
| MEDRT | N0000009006 | Decreased Thromboxane Production | PE | has_pe | aspirin |
| MEDRT | N0000009197 | Increased Central Nervous System Organized Electrical Activity | PE | has_pe | caffeine |
| MEDRT | N0000000026 | Hepatic Metabolism | PK | has_pk | aspirin |
| MEDRT | N0000000042 | Renal Excretion | PK | has_pk | aspirin |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | PRESCRIBABLE | Y |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | TTY | SBDC |
| CODES | RxCUI | 1053325 |
| NAMES | RXNAV_STR | aspirin 845 MG / caffeine 65 MG [Stanback Headache Powder Reformulated Jan 2011] |
| NAMES | RxNorm Name | aspirin 845 MG / caffeine 65 MG [Stanback Headache Powder Reformulated Jan 2011] |